Medicis Pharmaceutical Corporation (NYSE: MRX) reports Q2 EPS of $0.56, 6 cents better than ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE